SKLB-D18
Product Specifications
Target
ERK
Applications
MAPK
Additionnal Information
SKLB-D18 is a first-in-class, potent, and selective inhibitor of ERK1/2 and ERK5 with an IC50's of 38.69 nM, 40.12 nM, and 59.72 nM, respectively, that also acts as an agonist of autophagy. It modulates mTOR/p70S6K and NCOA4-mediated ferroptosis, showing strong anti-tumor activity and offering a promising monotherapy strategy to overcome resistance in ERK1/2-targeted therapy for triple-negative breast cancer (TNBC) .
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
143452-01 5 µg
NOV, Recombinant, Human (Protein NOV Homolog, NovH, Insulin-like Growth Factor-binding Protein 9, IGF-binding Protein 9, IGFBP-9, IBP-9, Nephroblastoma Overexpressed Gene Protein Homolog, CCN Family Member 3, NOVH, IGFBP9, CCN3) discontinued
Sign In for Pricing
View Details 143452-02 20 µg
NOV, Recombinant, Human (Protein NOV Homolog, NovH, Insulin-like Growth Factor-binding Protein 9, IGF-binding Protein 9, IGFBP-9, IBP-9, Nephroblastoma Overexpressed Gene Protein Homolog, CCN Family Member 3, NOVH, IGFBP9, CCN3) discontinued
Sign In for Pricing
View Details C2099-68Z-ML405 100 µL
CNOT8, CT (CCR4-NOT Transcription Complex Subunit 8, CCR4-associated Factor 8, CAF1-like Protein, CALIFp, CAF2, POP2, CALIF) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
LV674689 1.0 µg DNA
RIBC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details K3271606 1.0 µg DNA
Otud4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details